IBT
GMDA

International Biotechnology Trust’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

International Biotechnology Trust’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-187
Closed -$107K – 81
2022
Q2 		$107K Sell
187
-106,813
-100% -$271K 1.12% 27
2022
Q1 		$9.98M Hold
107,000
– – 2.25% 18
2021
Q4 		$271K Hold
107,000
– – 0.06% 69
2021
Q3 		$418K Hold
107,000
– – 0.1% 61
2021
Q2 		$682K Hold
107,000
– – 0.18% 56
2021
Q1 		$862K Buy
+107,000
New +$982K 0.23% 50

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KHLMTHM
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet Tel Aviv, Israel $506M AUM 21.19% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

International Biotechnology Trust's GMDA Position: Q3 2022 in Review

International Biotechnology Trust sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2022, closing a stake of 187 shares — an estimated $107K sold.

International Biotechnology Trust first reported a position in GMDA in Q1 2021 and held it in 6 quarters. The position peaked at $9.98M in Q1 2022. 62 funds tracked by Wall St. Rank hold GMDA as of Q3 2022.

  • International Biotechnology Trust reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 187 Gamida Cell Ltd. Ordinary Shares shares in Q3 2022, an estimated $107K.
  • International Biotechnology Trust first reported a position in Gamida Cell Ltd. Ordinary Shares in Q1 2021 and held it in 6 quarters.
  • International Biotechnology Trust's Gamida Cell Ltd. Ordinary Shares position peaked at $9.98M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2022.

Based on International Biotechnology Trust's 13F filing for Q3 2022, filed 8 Nov 2022.